Suffering Novartis partner Conatus grabs the ax and packs it in on NASH after a series of setbacks
The NASH party is over at Novartis-backed Conatus. And this time they’re turning off the lights.
More than 2 years after Novartis surprised the biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
